$6 million Alzheimer grant announced

Jun 04, 2007

The U.S. National Institutes of Health has awarded a $6 million grant for the continuation of a promising study into Alzheimer's disease treatments.

The grant was awarded University of Missouri-Columbia biochemistry Professors Grace Sun and Gary Weisman, who are entering the second phase of a project aimed at identifying the causes of Alzheimer's disease.

As many as 20 million people worldwide are affected by Alzheimer's disease, with those numbers likely to triple by 2050 as the population ages.

"In the past five years, we have started to understand how this disease works," Sun said. "With the new grant, we will be able to go forward and see if there are treatments that can modify the cellular response in the brain."

Findings from the research program have been published in the Journal of Neuroinflammation, the Journal of Neuroscience and the Journal of Biological Chemistry.

Copyright 2007 by United Press International

Explore further: Sierra Leone streets deserted as shutdown begins

add to favorites email to friend print save as pdf

Related Stories

Engineering light-controlled proteins

Jul 03, 2014

(Phys.org) —A University of Wyoming professor has engineered proteins that can be activated by near-infrared light as a way to control biological activities in deep tissues of small mammals.

Recommended for you

Sierra Leone streets deserted as shutdown begins

7 hours ago

Sierra Leone's normally chaotic capital resembled a ghost town on Friday as residents were confined to their homes for the start of a three-day lockdown aimed at halting the deadly Ebola epidemic.

Sierra Leone launches controversial Ebola shutdown

8 hours ago

Sierra Leone on Friday launched a controversial three-day shutdown to contain the deadly spread of the Ebola virus, as the UN Security Council declared the deadly outbreak a threat to world peace.

Cooling of dialysis fluids protects against brain damage

21 hours ago

While dialysis can cause blood pressure changes that damage the brain, cooling dialysis fluids can protect against such effects. The findings come from a study appearing in an upcoming issue of the Journal of the American So ...

Two Ebola vaccines to be tested in Switzerland

22 hours ago

Clinical trials of two experimental vaccines against the deadly Ebola virus are due to begin soon in Switzerland, the country's Tropical and Public Health Institute said on Thursday.

User comments : 0